Sam Meyer is a Head of AI / Director of AI for regulated industries.

At Bristol Myers Squibb I owned the enterprise generative-AI portfolio for a global Medical Affairs organization: a production RAG platform serving ~2,000 users across 50+ markets, an ~$8M annual book, governed under GxP and 21 CFR Part 11.

Head of AI who still writes the code. Twenty years connecting executive strategy to delivery, hands-on with LLM and agentic systems since 2021. Senior enough to align a VP/SVP room, technical enough to pressure-test the architecture.

What I do

• Turn ambiguous business problems into governed enterprise AI capabilities that survive Legal, Compliance, IT, and real production use.
• Own AI strategy, roadmap, ROI, the production RAG platform, the evaluation rubrics, and Generative AI governance under GxP / 21 CFR Part 11.
• Ship RAG, Agentic AI, MCP servers, and evaluation harnesses in Python and TypeScript.

Proof

• Owned an ~$8M annual GenAI and digital portfolio serving Global Medical Affairs, a production RAG platform serving ~2,000 users across 50+ markets.
• Led a $74B Celgene M&A technology integration across 20+ platforms, 1,500+ users, and 50+ markets in 18 months.
• Delivered $7M in operating efficiency and $4.3M in annual cost avoidance through industry-first componentized Medical content.
• Generated $6.5M in advisory revenue and $31M in pipeline as co-lead of PwC's digital public health practice.

Fit

Open to Head of AI, Director of AI, Senior Director AI, VP of AI, and Principal AI roles in regulated industries: pharmaceutical and life sciences, financial services, healthcare, and the public sector. Based in the Philadelphia metro (Doylestown, PA), remote-first, US citizen, no sponsorship required. PMP, ITIL Expert, and CPHIMS certified.